Cogent Biosciences Inc (NASDAQ:COGT) currently has a daily average trading volume of 1.48M but it saw 2012791 shares traded in last market. With a market cap of 822.05M USD, the company’s current market price of $7.22 came falling about -0.55 while comparing to the previous closing price of $7.26. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.61 and as low as $3.72. In the recent trading on the day, stock has struck highest price mark of $6.972 while lowest mark touched by it was $7.35.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Scotiabank which initiated the stock as “Sector Outperform” in its note to investors issued on March 07, 2025, recommending a price target of $17 for it. Robert W. Baird issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $14 and $8.
Over the week, COGT’s stock price is moving 20.53% up while it is 44.69% when we observe its performance for the past one month. Year-to-date it is -7.44% down and over the past year, the stock is showing a downside performance of -16.05%.
Currently, Cogent Biosciences Inc’s total number of outstanding shares is 113.86M with 0.16% of that held by the insiders while 118.66% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -109.60% and return on equity (ROE) at -84.04%. Stock’s beta reads 1.85. Stock has a price to book (P/B) ratio of 7.42. Its return on asset (ROA) is -70.93% on average.
